Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Kyoto University’s CiRA and Takeda to Develop DMD Treatment Using Genome-editing Technology

Filed Under: Innovation, Pharma Tagged With: , , , , ,

A team of researchers from Kyoto University’s Center of iPS Cell Research and Application (CiRA), led by Assistant Professor Akitsu…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Sumitomo Chemical Pursues Genome Editing for Agricultural Cultivation
Sumitomo Chemical Pursues Genome Editing for Agricultural…
Japan Makes Push for Domestically Developed Genome Editing Technologies
Japan Makes Push for Domestically Developed Genome Editing…
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Nippon Shokubai Uses Genome Editing for High-Yield Butanol Fermentation
Nippon Shokubai Uses Genome Editing for High-Yield Butanol…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…